These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pharmacokinetics and therapeutic drug monitoring of psychotropic drugs in pediatrics. Pichini S; Papaseit E; Joya X; Vall O; Farré M; Garcia-Algar O; de laTorre R Ther Drug Monit; 2009 Jun; 31(3):283-318. PubMed ID: 19363463 [TBL] [Abstract][Full Text] [Related]
23. Toxicity of tricyclic antidepressants--kinetics, mechanism, intervention: a review. Preskorn SH; Irwin HA J Clin Psychiatry; 1982 Apr; 43(4):151-6. PubMed ID: 7068546 [TBL] [Abstract][Full Text] [Related]
24. The value of assays in tricyclic antidepressant therapy. Clower CG Indiana Med; 1991 Aug; 84(8):550-2. PubMed ID: 1680895 [TBL] [Abstract][Full Text] [Related]
25. Tricyclic antidepressant plasma level monitoring: an improvement over the dose-response approach. Preskorn SH J Clin Psychiatry; 1986 Jan; 47(1 Suppl):24-30. PubMed ID: 2867088 [TBL] [Abstract][Full Text] [Related]
26. Relationship between mirtazapine dose, plasma concentration, response, and side effects in clinical practice. Grasmäder K; Verwohlt PL; Kühn KU; Frahnert C; Hiemke C; Dragicevic A; von Widdern O; Zobel A; Maier W; Rao ML Pharmacopsychiatry; 2005 May; 38(3):113-7. PubMed ID: 15902580 [TBL] [Abstract][Full Text] [Related]
27. Tricyclic antidepressants: clinical use of plasma levels. Preskorn SH; Madakasira S J Kans Med Soc; 1981 Mar; 82(3):122-4, 134. PubMed ID: 7276685 [No Abstract] [Full Text] [Related]
29. The role of plasma concentrations in the use of tricyclic antidepressant drugs. Levine RR Prog Neuropsychopharmacol; 1979; 3(1-3):211-22. PubMed ID: 401340 [TBL] [Abstract][Full Text] [Related]
30. Protocols for the use of psychoactive drugs - Part II: protocol for the treatment of depression with tricyclic antidepressants. Coleman JH; Johnston JA; Callaway JT; May CN; Druff JH J Clin Psychiatry; 1981 Feb; 42(2):65-8. PubMed ID: 7462172 [No Abstract] [Full Text] [Related]
31. Monitoring of antidepressant drug plasma levels: the next ten years. Sjöqvist F Prog Neuropsychopharmacol; 1979; 3(1-3):201-10. PubMed ID: 401339 [TBL] [Abstract][Full Text] [Related]
33. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study]. Ballon N; Siobud-Dorocant E; Even C; Slama F; Dardennes R Encephale; 2001; 27(4):373-6. PubMed ID: 11686060 [TBL] [Abstract][Full Text] [Related]
34. Tricyclic antidepressants: contemporary issues for therapeutic practice. Pollock BG; Perel JM Can J Psychiatry; 1989 Aug; 34(6):609-17. PubMed ID: 2670183 [TBL] [Abstract][Full Text] [Related]
35. Drug level monitoring in psychopharmacology: usefulness and clinical problems, with special reference to tricyclic antidepressants. Gram LF; Pedersen OL; Kristensen CB; Bjerre M; Kragh-Sørensen P Ther Drug Monit; 1982; 4(1):17-25. PubMed ID: 7041335 [TBL] [Abstract][Full Text] [Related]
36. Interference of carbamazepine and carbamazepine 10,11-epoxide in the fluorescence polarization immunoassay for tricyclic antidepressants: estimation of the true tricyclic antidepressant concentration in the presence of carbamazepine using a mathematical model. Dasgupta A; McNeese C; Wells A Am J Clin Pathol; 2004 Mar; 121(3):418-25. PubMed ID: 15023047 [TBL] [Abstract][Full Text] [Related]
37. [Review of findings on binding of tricyclic antidepressants]. Krulík R; Fisar Z Cesk Psychiatr; 1993 Apr; 89(2):71-8. PubMed ID: 8403025 [TBL] [Abstract][Full Text] [Related]
38. Antidepressant-induced mood conversions in bipolar disorder: a retrospective study of tricyclic versus non-tricyclic antidepressant drugs. Koszewska I; Rybakowski JK Neuropsychobiology; 2009; 59(1):12-6. PubMed ID: 19221443 [TBL] [Abstract][Full Text] [Related]
39. [Toxic tricyclic drug plasma level caused by fluoxetine]. Hambrecht M Psychiatr Prax; 1995 Nov; 22(6):252-3. PubMed ID: 8570758 [TBL] [Abstract][Full Text] [Related]
40. Ultrarapid metabolism of clomipramine in a therapy-resistant depressive patient, as confirmed by CYP2 D6 genotyping. Baumann P; Broly F; Kosel M; Eap CB Pharmacopsychiatry; 1998 Mar; 31(2):72. PubMed ID: 9562213 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]